Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-3.13 %
$ 1.15 B
Market Cap
-8.01
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Liquidia Corporation
| Revenue | 14 M |
| Cost Of Revenue | 5.88 M |
| Gross Profit | 8.12 M |
| Operating Expenses | 129 M |
| Operating Income | -121 M |
| Other Expenses | 9.1 M |
| Net Income | -130 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 14.0 | 17.5 | 15.9 | 12.9 | 0.7 | 8.1 | 2.7 | 7.3 | 13.2 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 5.9 | 2.9 | 2.9 | 3.0 | 0.2 | 0.8 | 0.1 | 0.3 | 0.9 |
| Gross Profit | 8.1 | 14.6 | 13.1 | 9.8 | 0.5 | 7.3 | 2.6 | 6.9 | 12.3 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 129.4 | 88.0 | 51.8 | 43.6 | 59.6 | 54.1 | 37.5 | 35.0 | 28.2 |
| Selling, General and Administrative Expenses | 81.6 | 44.7 | 32.4 | 23.1 | 27.4 | 13.6 | 8.8 | 10.2 | 4.8 |
| Research and Development Expenses | 47.8 | 43.2 | 19.4 | 20.5 | 32.2 | 40.5 | 28.7 | 24.8 | 23.3 |
| Operating Income | (121.3) | (73.4) | (38.8) | (33.8) | (59.1) | (46.8) | (34.9) | (28.0) | (15.9) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 12.5 | 6.3 | 2.3 | 0.8 | 0.9 | 1.4 | 19.0 | 13.0 | 85.9 K |
| Total Other Income | (9.1) | (5.1) | (2.2) | (0.8) | (0.7) | (0.8) | (18.3) | (1.1) | 71 K |
| Pre-Tax Income | (130.4) | (78.5) | (41.0) | (34.6) | (59.8) | (47.6) | (53.1) | (29.2) | (15.9) |
| NET INCOME | |||||||||
| Tax Provision | 0 | 0 | (2.6) | (4.8) | (2.3) | (1.2) | 0.7 | 13.0 | 14.9 K |
| Net Income | (130.4) | (78.5) | (38.4) | (29.8) | (57.5) | (46.4) | (53.1) | (29.2) | (15.9) |
| EPS | 1.66 | 1.21 | 0.63 | 0.6 | 1.7 | 2.51 | 7.42 | 3.4 | 3.13 |